Dietary intake and plasma metabolomic analysis of polyunsaturated fatty acids in bipolar subjects reveal dysregulation of linoleic acid metabolism

Journal of Psychiatric Research

Volumn 57, Issue 1, 2014, Pages 58-64

  Evans, Simon J ^a   Ringrose, Rachel N ^a   Harrington, Gloria J ^a   Mancuso, Peter ^b   Burant, Charles F ^b   McInnis, Melvin G ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Atypical antipsychotics; Eicosadienoic acid; Hydroperoxy octadecadienoic acid; Omega 3; Omega 6

Indexed keywords

ARACHIDIC ACID; BEHENIC ACID; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; POLYUNSATURATED FATTY ACID; PROSTAGLANDIN; SELENIUM; ARACHIDONIC ACID; FAT INTAKE; OMEGA 3 FATTY ACID; UNSATURATED FATTY ACID; PROSTAGLANDIN E1; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN G2; SATURATED FATTY ACID;

ADULT; ARTICLE; BIPOLAR I DISORDER; CALORIC INTAKE; CONTROLLED STUDY; DIETARY INTAKE; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; FEMALE; HUMAN; LIPID PEROXIDATION; LIPIDOMICS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MENTAL PATIENT; METABOLITE; METABOLOMICS; MIDDLE AGED; PRIORITY JOURNAL; ADMINISTRATION AND DOSAGE; BIPOLAR DISORDER; BLOOD; DIET; FAT INTAKE; METABOLISM; REGRESSION ANALYSIS; RISK FACTOR; STATISTICS AND NUMERICAL DATA; BODY MASS; CHILD; PEROXIDATION; PLASMA;

ADULT; ARACHIDONIC ACID; BIPOLAR DISORDER; DIET SURVEYS; DIETARY FATS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; LINOLEIC ACID; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RISK FACTORS; SELENIUM;

EID: 84905565457     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2014.06.001     Document Type: Article

References (39)

1. Anton S.D., Heekin K., Simkins C., Acosta A. Differential effects of adulterated versus unadulterated forms of linoleic acid on cardiovascular health. J Integr Med 2013, 11:2-10.
2. Arterburn L.M., Hall E.B., Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr 2006, 83:1467S-1476S.
3. Balanza-Martinez V., Fries G.R., Colpo G.D., Silveira P.P., Portella A.K., Tabares-Seisdedos R., et al. Therapeutic use of omega-3 fatty acids in bipolar disorder. Expert Rev Neurother 2011, 11:1029-1047.
4. Basu S. Bioactive eicosanoids: role of prostaglandin F(2alpha) and F(2)-isoprostanes in inflammation and oxidative stress related pathology. Mol Cells 2010, 30:383-391.
5. Begley C.E., Annegers J.F., Swann A.C., Lewis C., Coan S., Schnapp W.B., et al. The lifetime cost of bipolar disorder in the US: an estimate for new cases in 1998. Pharmacoeconomics 2001, 19:483-495.
6. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959, 37:911-917.
7. Cerit C., Vural M., Bos Gelmez S.U., Ozten E., Aker A.T., Yildiz M. Metabolic syndrome with different antipsychotics: a multicentre cross-sectional study. Psychopharmacol Bull 2010, 43:22-36.
8. Choque B., Catheline D., Rioux V., Legrand P. Linoleic acid: between doubts and certainties. Biochimie 2014, 96:14-21.
9. Davison K.M., Kaplan B.J. Food intake and blood cholesterol levels of community-based adults with mood disorders. BMC Psychiatry 2012, 12:10.
10. Ellingrod V.L., Taylor S.F., Brook R.D., Evans S.J., Zollner S.K., Grove T.B., et al. Dietary, lifestyle and pharmacogenetic factors associated with arteriole endothelial-dependent vasodilatation in schizophrenia patients treated with atypical antipsychotics (AAPs). Schizophr Res 2011, 130:20-26.
11. Evans S.J., Kamali M., Prossin A.R., Harrington G.J., Ellingrod V.L., McInnis M.G., et al. Association of plasma omega-3 and omega-6 lipids with burden of disease measures in bipolar subjects. J Psychiatr Res 2012 Nov, 46(11):1435-1441. 10.1016/j.jpsychires.2012.07.016.
12. Evans S.J., Prossin A.R., Harrington G.J., Kamali M., Ellingrod V.L., Burant C.F., et al. Fats and factors: lipid profiles associate with personality factors and suicidal history in bipolar subjects. PLoS One 2012, 7:e29297.
13. Fritsche K.L. Too much linoleic acid promotes inflammation-doesn't it?. Prostaglandins Leukot Essent Fatty Acids 2008, 79:173-175.
14. Hibbeln J.R., Nieminen L.R., Blasbalg T.L., Riggs J.A., Lands W.E. Healthy intakes of n-3 and n-6 fatty acids: estimations considering worldwide diversity. Am J Clin Nutr 2006, 83:1483S-1493S.
15. Irmisch G., Schlafke D., Gierow W., Herpertz S., Richter J. Fatty acids and sleep in depressed inpatients. Prostaglandins Leukot Essent Fatty Acids 2007, 76:1-7.
16. Jacka F.N., Pasco J.A., Mykletun A., Williams L.J., Nicholson G.C., Kotowicz M.A., et al. Diet quality in bipolar disorder in a population-based sample of women. J Affect Disord 2011, 129:332-337.
17. Kalinski P. Regulation of immune responses by prostaglandin E2. J Immunol 2012, 188:21-28.
18. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005, 62:593-602.
19. Kilbourne A.M., Rofey D.L., McCarthy J.F., Post E.P., Welsh D., Blow F.C. Nutrition and exercise behavior among patients with bipolar disorder. Bipolar Disord 2007, 9:443-452.
20. Langenecker S.A., Saunders E.F., Kade A.M., Ransom M.T., McInnis M.G. Intermediate: cognitive phenotypes in bipolar disorder. J Affect Disord 2010, 122:285-293.
21. Lazarus J.H. Lithium and thyroid. Best Pract Res Clin Endocrinol Metab 2009, 23:723-733.
22. Liu Y., McNamara R.K. Elevated Delta-6 desaturase (FADS2) gene expression in the prefrontal cortex of patients with bipolar disorder. J Psychiatr Res 2011, 45:269-272.
23. Luci S., Bettzieche A., Brandsch C., Eder K. Research paper effects of 13-HPODE on expression of genes involved in thyroid hormone synthesis, iodide uptake and formation of hydrogen peroxide in porcine thyrocytes. Int J Vitam Nutr Res 2006, 76:398-406.
24. McNamara R.K., Jandacek R., Rider T., Tso P., Cole-Strauss A., Lipton J.W. Differential effects of antipsychotic medications on polyunsaturated fatty acid biosynthesis in rats: relationship with liver delta6-desaturase expression. Schizophr Res 2011, 129:57-65.
25. Mocking R.J., Lok A., Assies J., Koeter M.W., Visser I., Ruhe H.G., et al. Ala54Thr fatty acid-binding protein 2 (FABP2) polymorphism in recurrent depression: associations with fatty acid concentrations and waist circumference. PLoS One 2013, 8:e82980.
26. Montgomery P., Richardson A.J. Omega-3 fatty acids for bipolar disorder. Cochrane Database Syst Rev 2008, CD005169.
27. Noaghiul S., Hibbeln J.R. Cross-national comparisons of seafood consumption and rates of bipolar disorders. Am J Psychiatry 2003, 160:2222-2227.
28. Novick D.M., Swartz H.A., Frank E. Suicide attempts in bipolar I and bipolar II disorder: a review and meta-analysis of the evidence. Bipolar Disord 2010, 12:1-9.
29. Nurnberger J.I., Blehar M.C., Kaufmann C.A., York-Cooler C., Simpson S.G., Harkavy-Friedman J., et al. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry 1994, 51:849-859. discussion 863-844.
30. Park Y., Storkson J.M., Albright K.J., Liu W., Pariza M.W. Biological activities of conjugated fatty acids: conjugated eicosadienoic (conj. 20:2delta(c11,t13/t12,c14)), eicosatrienoic (conj. 20:3delta(c8,t12,c14)), and heneicosadienoic (conj. 21:2delta(c12,t14/c13,t15)) acids and other metabolites of conjugated linoleic acid. Biochim Biophys Acta 2005, 1687:120-129.
31. Pike N. Using false discovery rates for multiple comparisons in ecology and evolution. Methods Ecol Evol 2011, 2:278-282.
32. Rapoport S.I., Basselin M., Kim H.W., Rao J.S. Bipolar disorder and mechanisms of action of mood stabilizers. Brain Res Rev 2009, 61:185-209.
33. Rett B.S., Whelan J. Increasing dietary linoleic acid does not increase tissue arachidonic acid content in adults consuming Western-type diets: a systematic review. Nutr Metab (Lond) 2011, 8:36.
34. Tanaka T., Shen J., Abecasis G.R., Kisialiou A., Ordovas J.M., Guralnik J.M., et al. Genome-wide association study of plasma polyunsaturated fatty acids in the InCHIANTI Study. PLoS Genet 2009, 5:e1000338.
35. Turnbull T., Cullen-Drill M., Smaldone A. Efficacy of omega-3 fatty acid supplementation on improvement of bipolar symptoms: a systematic review. Arch Psychiatr Nurs 2008, 22:305-311.
36. Vedtofte M.S., Jakobsen M.U., Lauritzen L., Heitmann B.L. The role of essential fatty acids in the control of coronary heart disease. Curr Opin Clin Nutr Metab Care 2012, 15:592-596.
37. Wittwer J., Hersberger M. The two faces of the 15-lipoxygenase in atherosclerosis. Prostaglandins Leukot Essent Fatty Acids 2007, 77:67-77.
38. Wyatt R.J., Henter I. An economic evaluation of manic-depressive illness - 1991. Soc Psychiatry Psychiatr Epidemiol 1995, 30:213-219.
39. Yao J.K., Leonard S., Reddy R.D. Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients. Schizophr Res 2000, 42:7-17.